Involvement of hypoxia and inflammation in early pregnancy loss mediated by Shiga toxin type 2

Placenta

Volumn 36, Issue 6, 2015, Pages 674-680

  Sacerdoti, F ^a   Amaral, M M ^a   Aisemberg, J ^b   Cymeryng, C B ^b   Franchi, A M ^b   Ibarra, C ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Centre de Estudios Farmacologicos y Botanicos   (Argentina)

Author keywords

Hypoxia; Inflammation; Pregnancy loss; STEC; Stx2

Indexed keywords

GLOBOTRIAOSYLCERAMIDE; GLYCOSPHINGOLIPID; PIMONIDAZOLE; PROGESTERONE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VEROTOXIN 2; CERAMIDE TRIHEXOSIDE; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIRST TRIMESTER PREGNANCY; HYPOXIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NONHUMAN; PRENATAL GROWTH; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT; SPONTANEOUS ABORTION; THIN LAYER CHROMATOGRAPHY; WESTERN BLOTTING; ANIMAL; ANOXIA; CHEMICALLY INDUCED; METABOLISM; PATHOLOGY; PREGNANCY; SPRAGUE DAWLEY RAT;

ABORTION, SPONTANEOUS; ANIMALS; ANOXIA; FEMALE; INFLAMMATION; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; SHIGA TOXIN 2; TRIHEXOSYLCERAMIDES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84929654836     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2015.03.005     Document Type: Article

References (35)

1. D. Warburton, and F.C. Fraser Spontaneous abortion risks in man: data from reproductive histories collected in a medical genetics unit Am J Hum Genet 16 1964 1 25
2. M. Matovina, K. Husnjak, N. Milutin, S. Ciglar, and M. Grce Possible role of bacterial and viral infections in miscarriages Fertil Steril 81 3 2004 662 669
3. K. Yoshimura, J. Fujii, A. Tanimoto, T. Yutsudo, M. Kashimura, and S. Yoshida Effects of Shiga toxin 2 on lethality, fetuses, delivery, and puerperal behavior in pregnant mice Infect Immun 68 4 2000 2254 2258
4. J. Burdet, E. Zotta, A.M. Franchi, and C. Ibarra Intraperitoneal administration of shiga toxin type 2 in rats in the late stage of pregnancy produces premature delivery of dead fetuses Placenta 30 6 2009 491 496
5. F. Sacerdoti, M.M. Amaral, E. Zotta, A.M. Franchi, and C. Ibarra Effects of Shiga toxin type 2 on maternal and fetal status in rats in the early stage of pregnancy Biomed Res Int 2014 2014 384645
6. J. Bergan, A.B. Dyve Lingelem, R. Simm, T. Skotland, and K. Sandvig Shiga toxins Toxicon 60 6 2012 1085 1107
7. T.G. Obrig, C.B. Louise, C.A. Lingwood, B. Boyd, L. Barley-Maloney, and T.O. Daniel Endothelial heterogeneity in Shiga toxin receptors and responses J Biol Chem 268 21 1993 15484 15488
8. M. Rivas, E. Miliwebsky, I. Chinen, N. Deza, and G.A. Leotta The epidemiology of hemolytic uremic syndrome in Argentina. Diagnosis of the etiologic agent, reservoirs and routes of transmission Medicina (B Aires) 66 Suppl. 3 2006 27 32
9. M.A. Karmali, M. Petric, C. Lim, P.C. Fleming, and B.T. Steele Escherichia coli cytotoxin, haemolytic-uraemic syndrome, and haemorrhagic colitis Lancet 2 8362 1983 1299 1300
10. T. Ulinski, C. Lervat, B. Ranchin, Y. Gillet, D. Floret, and P. Cochat Neonatal hemolytic uremic syndrome after mother-to-child transmission of Escherichia coli O157 Pediatr Nephrol 20 9 2005 1334 1335
11. M. Flandrois, A. Bessiere, S. Vieira-Roth, M. Vergnaud, V. Fremeaux-Bacchi, and P. Eckart Hemolytic and uremic syndrome and maternal-fetal Escherichia coli K1 infection Arch Pediatr 18 3 2011 283 286
12. D.A. Rasko, D.R. Webster, J.W. Sahl, A. Bashir, N. Boisen, and F. Scheutz Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany N Engl J Med 365 8 2011 709 717
13. M. Bielaszewska, E.A. Idelevich, W. Zhang, A. Bauwens, F. Schaumburg, and A. Mellmann Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain Antimicrob Agents Chemother 56 6 2012 3277 3282
14. C. Frank, D. Werber, J.P. Cramer, M. Askar, M. Faber, and M. an der Heiden Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany N Engl J Med 365 19 2011 1771 1780
15. B.T. Steele, J. Goldie, I. Alexopoulou, and A. Shimizu Post-partum haemolytic-uremic syndrome and verotoxin-producing Escherichia coli Lancet 1 8375 1984 511
16. T. Lienemann, E. Salo, R. Rimhanen-Finne, K. Ronnholm, M. Taimisto, and J.J. Hirvonen Shiga toxin-producing Escherichia coli serotype O78:H(-) in family, Finland, 2009 Emerg Infect Dis 18 4 2012 577 581
17. B.M. Fonseca, G. Correia-da-Silva, and N.A. Teixeira The rat as an animal model for fetoplacental development: a reappraisal of the post-implantation period Reprod Biol 12 2 2012 97 118
18. C.B. Cymeryng, L.A. Dada, and E.J. Podesta Effect of nitric oxide on rat adrenal zona fasciculata steroidogenesis J Endocrinol 158 2 1998 197 203
19. C.A. Lingwood Verotoxins and their glycolipid receptors Adv Lipid Res 25 1993 189 211
20. C.H. Schweppe, M. Bielaszewska, G. Pohlentz, A.W. Friedrich, H. Buntemeyer, and M.A. Schmidt Glycosphingolipids in vascular endothelial cells: relationship of heterogeneity in Gb3Cer/CD77 receptor expression with differential Shiga toxin 1 cytotoxicity Glycoconj J 25 4 2008 291 304
21. H. Raa, S. Grimmer, D. Schwudke, J. Bergan, S. Walchli, and T. Skotland Glycosphingolipid requirements for endosome-to-golgi transport of Shiga toxin Traffic 10 7 2009 868 882
22. N. Ferrara, H.P. Gerber, and J. LeCouter The biology of VEGF and its receptors Nat Med 9 6 2003 669 676
23. D. Maroeska Te Loo, N. Bosma, V. Van Hinsbergh, P. Span, R. De Waal, and R. Clarijs Elevated levels of vascular endothelial growth factor in serum of patients with D+ HUS Pediatr Nephrol 19 7 2004 754 760
24. S.P. Andreoli The pathophysiology of the hemolytic uremic syndrome Curr Opin Nephrol Hypertens 8 4 1999 459 464
25. P. Ruggenenti, M. Noris, and G. Remuzzi Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura Kidney Int 60 3 2001 831 846
26. F. Obata, and T. Obrig Role of Shiga/Vero toxins in pathogenesis Microbiol Spectr 2 3 2014
27. M.S. Lee, M.H. Kim, and V.L. Tesh Shiga toxins expressed by human pathogenic bacteria induce immune responses in host cells J Microbiol 51 6 2013 724 730
28. C. Zoja, S. Angioletti, R. Donadelli, C. Zanchi, S. Tomasoni, and E. Binda Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1 Kidney Int 62 3 2002 846 856
29. A. Matussek, J. Lauber, A. Bergau, W. Hansen, M. Rohde, and K.E. Dittmar Molecular and functional analysis of Shiga toxin-induced response patterns in human vascular endothelial cells Blood 102 4 2003 1323 1332
30. J. Burdet, F. Sacerdoti, M. Cella, A.M. Franchi, and C. Ibarra Role of TNF-alpha in the mechanisms responsible for preterm delivery induced by Stx2 in rats Br J Pharmacol 168 4 2013 946 953
31. C. Ibarra, M.M. Amaral, and M.S. Palermo Advances in pathogenesis and therapy of hemolytic uremic syndrome caused by Shiga toxin-2 IUBMB Life 65 10 2013 827 835
32. V.L. Tesh, J.E. Samuel, L.P. Perera, J.B. Sharefkin, and A.D. O'Brien Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells J Infect Dis 164 2 1991 344 352
33. C.B. Louise, and T.G. Obrig Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro Infect Immun 59 11 1991 4173 4179
34. M. Ben-Zimra, M. Koler, N. Melamed-Book, J. Arensburg, A.H. Payne, and J. Orly Uterine and placental expression of steroidogenic genes during rodent pregnancy Mol Cell Endocrinol 187 1-2 2002 223 231
35. Y. Sugimoto, A. Yamasaki, E. Segi, K. Tsuboi, Y. Aze, and T. Nishimura Failure of parturition in mice lacking the prostaglandin F receptor Science 277 5326 1997 681 683